Esterification of 8,11,14-eicosatrienoate and arachidonate into alkylacyl- and diacylglycerophosphocholine by vascular endothelial cells |
| |
Authors: | Miriam D Rosenthal Morris E Brown III Janet E Jones |
| |
Affiliation: | (1) Dept. of Biochemistry, Eastern Virginia Medical School, P.O. Box 1980, 23501 Norfolk, VA |
| |
Abstract: | Agonist-stimulated phospholipases release arachidonate, but not 8,11,14-eicosatrienoate, from human endothelial cells. One
source of the arachidonic acid is deacylation of 1-alkyl-2-arachidonoyl-glycerophosphocholine, with subsequent conversion
of some of the resultant lysophospholipid to platelet-activating factor. This study has compared the distribution of incorporated
8,11,14-14C]-eicosatrienoate in alkylacyl-GPC and diacyl-GPC with that of 14C]arachidonate synthesized endogenously by desaturation of the 8,11,14-14C]eicosatrienoate. Cells were incubated for 24 or 48 hr with 8,11,14-14C]eicosatrienoate, and the resultant mixture of14C-fatty acids in the cellular lipids was characterized by gas chromatography. The choline phospholipids were then separated,
hydrolyzed with phospholipase C and derivatized to diradylbenzoates. Gas chromatographic analysis indicated extensive incorporation
of 14C]eicosatrienoate, as well as 14C]arachidonate, into alkylacyl-GPC. Although the ratio of esterified 14C]arachidonate to 14C]eicosatrienoate was greater in alkylacyl-GPC than in diacyl-GPC, the enrichment with 14C]arachidonate was far less than the ratio of arachidonate/eicosatrienoate released from these cells. These results thus support
the hypothesis that the acyl specificity of polyunsaturated fatty acid release is provided by the agonist-stimulated phospholipase
A2 rather than the composition of the alkylacyl-GPC. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|